Omada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 637 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 637 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $23.00, for a total transaction of $14,651.00. Following the transaction, the chief accounting officer owned 15,441 shares in the company, valued at approximately $355,143. This represents a 3.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Craig Gracey also recently made the following trade(s):

• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total value of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total value of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Performance

OMDA traded down $0.23 during midday trading on Thursday, hitting $22.39. 835,372 shares of the company traded hands, compared to its average volume of 1,067,190. The business has a 50 day simple moving average of $17.16 and a two-hundred day simple moving average of $15.03. Omada Health, Inc. has a 52-week low of $10.28 and a 52-week high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The firm had revenue of $78.05 million during the quarter. Equities analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Quarry LP purchased a new stake in shares of Omada Health in the 4th quarter valued at approximately $29,000. TD Waterhouse Canada Inc. acquired a new stake in Omada Health in the 4th quarter valued at approximately $32,000. Raymond James Financial Inc. purchased a new stake in Omada Health in the second quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new position in Omada Health during the fourth quarter worth $45,000. Finally, Versant Capital Management Inc boosted its position in shares of Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after buying an additional 2,283 shares during the period.

Analyst Ratings Changes

A number of brokerages have recently commented on OMDA. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 target price on shares of Omada Health in a research report on Friday, May 8th. Canaccord Genuity Group set a $24.00 target price on Omada Health in a report on Friday, May 8th. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Barclays boosted their target price on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Finally, Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.